.svg){kind=small}
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
In October 2026, Happy Hounds CBD concentrated 92.62% of sales in Edible, with Tincture & Sublingual at 7.38%, while overall brand sales were down 4.11% year over year and average price declined 3.51%. Within the mix, Edible grew 4.34% YoY and 2.08% MoM, whereas Tincture & Sublingual contracted 52.45% YoY and 56.49% MoM, and the average price gap between the two ($33.48 vs. $39.86) widened the volume tilt toward the lower-priced format. The pattern implies category consolidation around Edible as the primary growth engine and an accelerated exit from Tincture & Sublingual that reduces diversification risk only if Edible’s 2.08% MoM momentum sustains against the 4.11% YoY brand decline.
Given Edible’s 92.62% share and positive 4.34% YoY trajectory alongside a 2.08% MoM lift, the brand is positioned as an Edible-first player in New York, trading a 7.38% Tincture & Sublingual niche for scale in a category where a 3.51% average price drop may be stoking volume. With Tincture & Sublingual down 56.49% MoM and 52.45% YoY, the mix shift suppresses premium-price exposure while amplifying reliance on Edible price elasticity, implying that short-term share defense hinges on keeping Edible velocity ahead of the brand’s -4.11% YoY trend and selectively pruning underperforming tincture SKUs.
Competitive Landscape
Happy Hounds CBD sits at rank 96 in NY Edible for October 2026, slipping 3 positions year over year from rank 93 and falling 10 spots from July 2026’s rank 86, while also sitting 21 places below its peak rank 75 from October 2024; in contrast, Off Hours fell from rank 1 to rank 2 as its sales declined 22.20% year over year, whereas Wyld improved from rank 4 to rank 3 on an 18.75% year-over-year sales increase. The combination of a long-run slide since October 2024 and a recent quarter-on-quarter drop suggests Happy Hounds CBD is losing relative shelf visibility as faster-moving rivals climb or consolidate near the top.
Notable Products
Happy Hounds CBD sells a concentrated lineup in October 2026, with two chew SKUs carrying 92.6% of sales through the Caramels, Chews and Taffy segment and the top CBD Calm + Joint Bacon Strips Chews 30-Pack (150mg CBD) alone at 47.1%. That leaves just 7.4% from tinctures, so most of its sales come from chews.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
